TABLE 3.
Markers with favorable prognosis | Markers with unfavorable prognosis |
---|---|
NPM1 mutation | FLT3 mutation |
CEBPA mutation | MLL-PTD |
BAALC overexpression | |
ERG overexpression | |
EVI1 overexpression | |
IDH1 mutation | |
IDH2 mutation | |
ABCG2 overexpression |
Markers with favorable prognosis | Markers with unfavorable prognosis |
---|---|
NPM1 mutation | FLT3 mutation |
CEBPA mutation | MLL-PTD |
BAALC overexpression | |
ERG overexpression | |
EVI1 overexpression | |
IDH1 mutation | |
IDH2 mutation | |
ABCG2 overexpression |